Lexicon Pharmaceuticals
LXRX
#7374
Rank
โ‚ฌ0.37 B
Marketcap
1,04ย โ‚ฌ
Share price
4.27%
Change (1 day)
30.35%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -โ‚ฌ63.95 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ70.86 Million. In 2024 the company made an earning of -โ‚ฌ0.18 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ63.95 Million-62.46%
2024 -โ‚ฌ0.18 Billion13.15%
2023 -โ‚ฌ0.16 Billion73.74%
2022 -โ‚ฌ86.66 Million16.16%
2021 -โ‚ฌ74.6 Million49.82%
2020 -โ‚ฌ49.79 Million-147.19%
2019 โ‚ฌ0.10 B-203.42%
2018 -โ‚ฌ0.11 Billion-15.31%
2017 -โ‚ฌ0.13 Billion0.2%
2016 -โ‚ฌ0.13 Billion2920.7%
2015 -โ‚ฌ3.98 Million-95.33%
2014 -โ‚ฌ85.31 Million-3.61%
2013 -โ‚ฌ88.51 Million-5.52%
2012 -โ‚ฌ93.68 Million-4.17%
2011 -โ‚ฌ97.76 Million15.5%
2010 -โ‚ฌ84.65 Million8.36%
2009 -โ‚ฌ78.11 Million-4.81%
2008 -โ‚ฌ82.06 Million28.79%
2007 -โ‚ฌ63.72 Million35.71%
2006 -โ‚ฌ46.95 Million52.91%
2005 -โ‚ฌ30.71 Million-23.89%
2004 -โ‚ฌ40.34 Million-24.19%
2003 -โ‚ฌ53.21 Million-0.48%
2002 -โ‚ฌ53.46 Million44.12%
2001 -โ‚ฌ37.1 Million23.01%
2000 -โ‚ฌ30.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-โ‚ฌ8.07 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.37 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.45 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.57 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ6.03 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ23.33 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ0.84 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ56.77 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ19.76 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA